No association between c-myc amplification and TP53 mutation in sarcoma tumorigenesis

Cancer Genet Cytogenet. 1994 Aug;76(1):47-9. doi: 10.1016/0165-4608(94)90070-1.

Abstract

Oncogenes and tumor suppressor genes coparticipate in sarcoma tumorigenesis. We tested 43 sarcomas for c-myc amplification by Southern blot and molecular hybridization techniques and TP53 mutations by the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) technique and direct sequencing of the PCR products. We found eight tumors with c-myc amplification and five different tumors with TP53 mutations but no tumors harbor both c-myc and TP53 alterations. We suggest that c-myc amplification and TP53 mutations do not seem to coparticipate in the tumorigenesis of sarcomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cell Transformation, Neoplastic / genetics*
  • Exons
  • Gene Amplification
  • Genes, myc / genetics*
  • Genes, p53 / genetics*
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Polymerase Chain Reaction
  • Sarcoma / genetics*